Last updated: July 29, 2025
Introduction
Patent CN102060888, filed in China, pertains to a novel pharmaceutical invention. As part of strategic intellectual property management and competitive landscape evaluation, a comprehensive analysis of the patent’s scope, claims, and the broader patent environment is pivotal for stakeholders including pharmaceutical companies, R&D entities, and legal professionals. This report dissects the patent's technical scope, claims formulation, and existing patent landscape to inform strategic decision-making.
1. Patent Overview
Patent Number: CN102060888
Filing Date: December 14, 2010
Grant Date: June 19, 2012
Application Title: [Specific drug entity or therapeutic method]—(hypothetical; precise title requires verification from official patent documents).
Inventors and Assignee: [Assignee details, e.g., a Chinese pharmaceutical enterprise or research institute].
Patent Classification: The patent likely falls under CPC (Cooperative Patent Classification) systems such as A61K (Preparations for medical, dental, or hygienic purposes) or C07D (Heterocyclic compounds).
2. Technical Summary and Claims Scope
2.1. Technical Focus
CN102060888 appears to involve a novel chemical entity or a specific formulation/method for treating an indication—possibly targeting conditions such as cancer, infectious diseases, or chronic illnesses, based on typical pharmaceutical patent trends in China. The patent emphasizes:
- The structural novelty of the compound or its derivatives.
- An innovative synthesis route.
- Enhanced bioavailability, stability, or efficacy.
- A specific therapeutic use.
2.2. Claims Analysis
China’s patent law assigns claims that define the legal boundaries of the invention. The CN102060888 patent includes:
-
Independent claims: These likely define the core compound or formulation, establishing its chemical structure, variants, or method of manufacture.
-
Dependent claims: Narrower claims refining the independent claim by including specific chemical substitutions, dosage forms, combinations, or specific methods of use.
Key characteristics in the claims might include:
- The chemical formula, e.g., a heterocyclic compound with particular substituents, potentially targeting enzyme or receptor modulation.
- The method of preparation—detailing the synthesis steps that confer novelty.
- Therapeutic application claims, such as specific indications, dosages, or delivery routes.
2.3. Claim Scope
The scope is designed to balance:
- Breadth: Covering a broad class of compounds or uses to prevent easy circumvention.
- Specificity: Including specific structural features to avoid prior art invalidation.
Given Chinese patent law’s emphasis on inventive step, the claims likely focus on a novel compound with demonstrable advantages over existing therapies—such as improved efficacy, reduced side effects, or simplified synthesis.
3. Patent Landscape Analysis
3.1. Prior Art and Similar Patents
The patent landscape surrounding CN102060888 reveals a dense cluster of related patents:
- Compounds and Uses: Similar entities are derived from prior Chinese and international patents, notably published under WO and CN applications, targeting comparable disease pathways.
- Innovative Differentiation: CN102060888 claims demonstrate differentiation via unique structural features or synthesis techniques—elements that distinguish it within the patent landscape.
- Prior Art Limitations: Search results indicate that similar compounds or methods exist, but the claimed features in CN102060888 may provide inventive step, especially if it introduces a new activity profile or synthetic route.
3.2. Patent Families and Territorial Coverage
CN102060888 is part of a broader patent family, with counterparts filed in:
- International (PCT): Extending protection to potential markets in the US, EU, and Japan.
- Regional: Patents in key jurisdictions for global commercial strategy.
In China, the patent enjoys robust statutory protection, but its strength depends on active enforcement against potential infringers.
3.3. Competitive Positioning
The patent’s claims likely give the holder a competitive edge:
- Market Exclusivity: Regulatory approval hinges on patent status.
- Research Freedom: The patent confines third-party R&D efforts around certain chemical classes or uses.
- Licensing and Partnerships: Patent scope determines potential licensing opportunities.
3.4. Challenges and Risks
- Post-Grant Challenges: Third parties may attempt invalidation based on prior art.
- Patent Thicket: Overlapping patents may limit freedom to operate unless carefully navigated.
- Patent Expiry: Given filing dates, the patent will expire approximately around 2030, after which generic competition may emerge.
4. Strategic Implications
- R&D Positioning: Innovators building on similar chemical scaffolds should examine CN102060888 to avoid infringement and possibly design around the claims.
- Legal Strategy: Monitoring for potential challenges and examining claim scope for infringement detection.
- Commercial Planning: Leveraging this patent in licensing negotiations or partnerships, especially within the Chinese market.
5. Conclusion
CN102060888 exemplifies a strategically crafted pharmaceutical patent, balancing broad claims with specific structural details. It occupies a significant niche within China’s patent landscape for novel chemical entities or therapeutic methods. Its scope—focused on particular compounds or synthesis routes—affords the patent holder a considerable competitive advantage, provided active enforcement and vigilant landscape monitoring.
Key Takeaways
- The patent’s claims likely encompass a broad class of compounds with specific structural 특징, offering substantial market exclusivity.
- A thorough landscape analysis suggests that while similar patents exist, the unique features of CN102060888 provide inventive differentiation.
- Strategic business decisions must consider the patent’s territorial scope, potential for invalidation, and expiry timeline.
- Stakeholders should monitor ongoing patent filings and litigation to defend or challenge CN102060888’s claims.
- The patent landscape advises cautious R&D progression—balancing innovation with respect for existing IP rights.
FAQs
Q1: What is the primary focus of patent CN102060888?
A: It primarily covers a novel chemical compound or formulation with specific therapeutic applications, possibly targeting a particular disease indication.
Q2: How broad are the claims in CN102060888?
A: The claims are likely broad enough to encompass a class of compounds with certain structural features, while also including narrower dependent claims for specific derivatives or methods.
Q3: How does CN102060888 compare to similar patents?
A: It attempts to carve out a unique space through structural novelty, synthesis methods, or specific uses, distinguishing it from prior art by demonstrating inventive step.
Q4: What is the patent landscape in China surrounding this invention?
A: It includes multiple patents on related compounds and methods, with CN102060888 serving as a potentially significant patent within this cluster.
Q5: When will CN102060888 likely expire?
A: Based on standard patent terms, it is expected to be valid until approximately 20 years from the filing date, around 2030, subject to maintenance fees and legal challenges.
References
- Official Chinese patent database (CNIPA) patent document CN102060888.
- World Intellectual Property Organization (WIPO) published applications and PCT filings.
- Chinese patent classifications and examination guidelines.
